Melissa E. Hogg
NorthShore University HealthSystem, University of Pittsburgh, Apple (Israel), University of Pittsburgh Medical Center, King's Fund, UPMC Health System, Fondazione Poliambulanza Istituto Ospedaliero, Walgreens (United States), North Park University, West Virginia University, Virginia Mason Medical Center
Papers
117
Total Citations
4,978
H-Index
38
About
Melissa E. Hogg is a pioneering surgical oncologist whose career has fundamentally shaped the field of minimally invasive pancreatic surgery, with particular expertise in robotic-assisted techniques. Her work has focused on advancing robotic pancreaticoduodenectomy (RPD) and distal pancreatectomy, rigorously establishing their safety, efficacy, and reproducibility compared to traditional open approaches. Among her most influential contributions are landmark multicenter studies demonstrating comparable or superior perioperative outcomes for robotic procedures, work that has collectively garnered hundreds of citations — including over 478 for the Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection and 368 for her quality outcomes assessment of RPD. Hogg has been especially innovative in addressing surgical education, developing mastery-based virtual reality simulation curricula and structured training programs such as LAELAPS-3, ensuring the safe dissemination of complex robotic techniques across institutions. Her pioneering series of 500 robotic pancreatoduodenectomies stands as a milestone in the field. Through international guideline development and rigorous outcomes research, Hogg has not only elevated the standard of pancreatic surgery but also created a blueprint for responsibly implementing transformative surgical technology worldwide.
Research Focus
Key Achievements
Top Papers
- 1
- 2Assessment of Quality Outcomes for Robotic Pancreaticoduodenectomy368 citations · 2015
- 3
- 4500 Minimally Invasive Robotic Pancreatoduodenectomies199 citations · 2019
- 5
- 6
- 7
- 8
- 9
- 10